First Ebola vaccine to start human trials in the UK

Oxford Launches First Ebola Bundibugyo Vaccine Trial

Published 6 days ago

story

Image credit:

The Spin

Oxford's launch of the world's first Bundibugyo ebolavirus vaccine trial is exactly the kind of rapid, coordinated global response that saves lives. Built on the same platform as the Oxford/AstraZeneca COVID-19 vaccine, the ChAdOx1 BDBV candidate reached human trials just 57 days after the WHO declared an emergency. With 620,000 doses already stockpiled, this is science moving at the speed the moment demands.

Pharmaphorum Oxford Academic

The Bundibugyo outbreak has already killed over 700 people and is still growing, and the U.S. has rightly prioritized keeping it off American soil. A U.S. citizen has already contracted Ebola, and the State Department has issued a do-not-travel order for Congo. Early-stage vaccine trials are a long-term play — protecting Americans right now has to come first.

X The Epoch Times